Zoetis Inc. (ZTS): Shareholders' Equity
$3.33B
As of 2025-12-31
$3.15B
As of 2026-06-30
-8.9%
3-year compound annual growth
-2.5%
5-year compound annual growth
+11.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.33B | -30.2% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $4.77B | -4.4% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $4.99B | +13.4% | 2026-02-12, Balance as of period end |
| 2022-12-31 | $4.40B | -3.1% | 2025-02-13, Balance as of period end |
| 2021-12-31 | $4.54B | +20.4% | 2024-02-13, Balance as of period end |
| 2020-12-31 | $3.77B | +39.3% | 2023-02-14, Balance as of period end |
| 2019-12-31 | $2.71B | +23.9% | 2022-02-15, Balance as of period end |
| 2018-12-31 | $2.19B | +22.3% | 2021-02-16, Balance as of period end |
| 2017-12-31 | $1.79B | +19.1% | 2020-02-13, Balance as of period end |
| 2016-12-31 | $1.50B | +37.4% | 2019-02-14, Balance as of period end |
| 2015-12-31 | $1.09B | -18.4% | 2018-02-15, Balance as of period end |
| 2014-12-31 | $1.34B | +39.0% | 2017-02-16, Balance as of period end |
| 2013-12-31 | $962.00M | -76.2% | 2016-02-24, Balance as of period end |
| 2012-12-31 | $4.04B | +8.2% | 2015-02-27, Balance as of period end |
| 2011-12-31 | $3.74B | n/a | 2014-03-26, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.33B | -30.2% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $377.00M | n/m |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $18.67B | +13.7% |
| Viatris Inc (VTRS) | 2025-12-31 | $14.71B | -21.1% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $31.26B | +6.5% |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $7.91B | +47.1% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
Compare ZTS, BHC, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗